Overview Request Sample Pages Request Customization Download PDF
You are viewing: New Zealand Companion Animal Diagnostic Market analysis

The New Zealand Companion Animal Diagnostic Market was valued at $15 Million in 2026 and projected to reach to $21.6 Million by 2031, representing a compound annual growth rate of 7.6%. New Zealand's companion animal diagnostic market is positioned for steady expansion through 2031, driven by increasing pet ownership rates and growing consumer awareness of preventive veterinary care.

New Zealand Companion Animal Diagnostic Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

New Zealand Companion Animal Diagnostic Market Trends and Insights

  • This 7.6% compound annual growth rate reflects increasing pet ownership and rising demand for advanced veterinary diagnostics across the country.
  • New Zealand pet owners are increasingly investing in preventive healthcare and early disease detection for their companion animals, driving adoption of diagnostic technologies in veterinary clinics and animal hospitals. The market in New Zealand is supported by a well-developed veterinary infrastructure and growing consumer awareness of pet health.
  • Between 2026 and 2031, New Zealand is expected to see heightened demand for point-of-care testing, imaging diagnostics, and laboratory services tailored to companion animals.
  • New Zealand's regulatory environment and strong emphasis on animal welfare further contribute to market expansion, positioning the country as a key growth market within the Asia Pacific region for companion animal diagnostics..

Key Market Statistics

  • CAGR (2026-2031) 7.6% CAGR
  • Market Size, 2026 ~USD 15 Million
  • Forecast, 2031 ~USD 21.6 Million
  • Country New Zealand

New Zealand Companion Animal Diagnostic Market Overview

Market Valuation Growth :

New Zealand's companion animal diagnostic market is valued at USD 15.0 million in 2026, with projections reaching USD 21.6 million by 2031, representing a robust 7.6% CAGR.

Pet Ownership Trends :

Rising pet ownership across New Zealand is driving increased demand for veterinary diagnostic services, with pet owners prioritizing preventive healthcare and early disease detection.

Advanced Diagnostic Adoption :

New Zealand veterinary clinics are increasingly adopting advanced diagnostic technologies, including imaging, laboratory testing, and point-of-care diagnostics for companion animals.

Preventive Healthcare Focus :

New Zealand pet owners demonstrate strong investment in preventive healthcare measures, creating sustained demand for routine diagnostic screening and wellness testing services.

New Zealand Companion Animal Diagnostic Market Dynamics

  • The market benefits from a developed veterinary infrastructure and affluent pet-owning population willing to invest in advanced diagnostic solutions.
  • Technological advancements in portable and point-of-care diagnostics are making services more accessible across urban and rural regions.
  • The 7.6% CAGR reflects consistent demand growth, though slightly below the global average of 8.7%, indicating a mature but expanding market.
  • Key growth opportunities exist in specialized diagnostics, digital health integration, and expanded rural clinic capabilities..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • New Zealand's companion animal diagnostic market is valued at USD 15.0 million in 2026 and will reach USD 21.6 million by 2031, representing a 7.6% CAGR.
    • New Zealand's well-developed veterinary infrastructure and high pet ownership rates drive demand for advanced diagnostic solutions.
    • Point-of-care testing and imaging diagnostics are key growth segments in New Zealand's companion animal diagnostic market.
    • New Zealand's strong animal welfare standards and regulatory framework support sustained market expansion through 2031.

    Companion Animal Diagnostic Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment MOLECULAR DIAGNOSTICS (Technology)
    Forecast Period 2026–2031
    Growth Rate CAGR of 8.7% from 2026 to 2031
    Largest Segment CONSUMABLES (Product)
    Market Size Base Year (Billions) ~USD 3.56 (2026)
    Revenue Forecast (Billions) ~USD 5.4 (2031)
    Segments Covered Product, Technology, Type, Application, Animal Type, End User

    New Zealand Companion Animal Diagnostic Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Consumables
    • Instruments

    By Technology

    • Clinical Biochemistry
    • Hematology
    • Immunodiagnostics
    • Molecular Diagnostics
    • Other Technologies
    • Urinalysis

    By Type

    • Allergen-Specific Immunodiagnostic Tests
    • Blood Gas & Electrolyte Analysis
    • Blood Gas & Electrolyte Analyzers
    • Blood Gas & Electrolyte Reagents, Clips, And Cartridges
    • Blood Glucose Strips
    • Clinical Chemistry Analysis
    • Clinical Chemistry Analyzers
    • Clinical Chemistry Reagents, Clips, And Cartridges
    • Elisa Tests
    • Glucose Monitoring
    • Glucose Monitors
    • Hematology Analyzers
    • Hematology Cartridges
    • Immunoassay Analyzers
    • Lateral Flow Assays
    • Microarrays
    • Nucleic Acid Sequencing
    • Other Immunodiagnostics Products
    • Other Molecular Diagnostics Products
    • Pcr Tests
    • Radioimmunoassays
    • Rapid Tests
    • Strip Readers
    • Urinalysis Clips & Cartridges
    • Urine Analyzers
    • Urine Glucose Strips
    • Urine Test Strips

    By Application

    • Bacteriology
    • Clinical Pathology
    • Other Applications
    • Parasitology
    • Virology

    By Animal Type

    • Cats
    • Dogs
    • Horses
    • Other Companion Animals

    By End User

    • Home Care Settings
    • Veterinary Hospital & Clinics
    • Veterinary Reference Laboratories
    • Veterinary Research Institutes & Universities

    Target Audience

    • Veterinary Diagnostic Equipment Manufacturers : Manufacturers need New Zealand-specific market data to assess demand for diagnostic equipment, identify distribution partnerships, and develop localized product strategies for the growing market.
    • Veterinary Clinic Operators : Clinic owners require market insights to justify investments in diagnostic capabilities, benchmark service offerings against regional trends, and plan expansion of diagnostic services.
    • Pet Insurance and Healthcare Companies : Insurance providers need market data to understand diagnostic service utilization rates, pricing trends, and coverage demand in New Zealand to optimize product offerings.
    • Investment and Private Equity Firms : Investors evaluating veterinary healthcare opportunities in New Zealand require detailed market sizing, growth projections, and regional dynamics to assess investment viability.
    • Veterinary Diagnostic Service Providers : Laboratory and diagnostic service companies need New Zealand market intelligence to identify growth opportunities, understand competitive positioning, and plan service expansion strategies.

    Key Companies in the New Zealand Companion Animal Diagnostic Market

    CompanyHQOwnershipStrongest segments
    MINDRAY MEDICAL INTERNATIONAL LIMITEDChinaPrivate CompanyPatient Monitoring and Life Support Products,In-Vitro Diagnostic Products,Medical Imaging Systems,
    QIAGEN NVNetherlandsPublic CompanySample technology consumables and instruments,Immune response and infectious disease diagnostics (incl. TB IGRA, transplant, viral load),Oncology, sexual and reproductive health assays,
    IDEXX LABORATORIES, INC.United StatesPublic CompanyCompanion Animal Group – in-clinic analyzers and SNAP rapid assays,Companion Animal Group – reference laboratories and telemedicine/consulting,Veterinary software, services, VetConnect PLUS and VetLab Station,
    FUJIFILM CORPORATIONJapanPublic CompanyHealthcare (medical devices, CDMO, pharma, regenerative medicine, cosmetics/supplements),Business Innovation (office equipment, document solutions, graphic communications, inkjet),Electronics (display, semiconductor materials, storage, industrial equipment, fine chemicals),
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    BIOMéRIEUXFrancePublic CompanyClinical microbiology (culture media, VITEK 2, VITEK MS, AST including ETEST/VITEK REVEAL),Syndromic and molecular diagnostics (BIOFIRE, BIOFIRE SPOTFIRE, ARGENE, EMAG/NUCLISENS),Immunoassays and CLIA (VIDAS, Hybiome),
    BIONOTESouth KoreaPublic CompanyVeterinary fluorescence immunoassay and molecular diagnostics,Veterinary clinical biochemistry systems and reagents,Veterinary rapid immunoassay and ELISA kits,
    VIRBACFrancePublic CompanyCompanion-animal parasiticides and anti-infectives,Companion-animal specialty therapeutics & behavior (CKD diets, pheromones, mobility),Farm-animal vaccines (swine focus: Suigen range),

    MINDRAY MEDICAL INTERNATIONAL LIMITED

    Mindray Medical International Limited is a Chinese medical device manufacturer founded in 1991 with 8,400 employees. Operating as a private company, it specializes in diagnostic and monitoring equipment for healthcare applications.

    QIAGEN NV

    QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. It provides molecular diagnostics, sample preparation, and life sciences research tools globally.

    IDEXX LABORATORIES, INC.

    IDEXX Laboratories, Inc. is a United States-based public company founded in 1983 with 11,000 employees. The company develops and manufactures diagnostic equipment and software for veterinary and water testing markets.

    FUJIFILM CORPORATION

    Fujifilm Corporation is a Japanese public company founded in 1934 with 73,526 employees. It operates across imaging, diagnostics, pharmaceuticals, and industrial products globally.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc. is a United States public company founded in 1956 with 125,000 employees. It is a leading provider of laboratory equipment, reagents, and analytical instruments worldwide.

    BIOMéRIEUX

    bioMérieux is a French public company founded in 1963 with 14,894 employees. It specializes in in vitro diagnostics and microbiology testing solutions for clinical and industrial applications.

    BIONOTE

    BioNote is a South Korean public company founded in 2003 with 298 employees. The company develops and manufactures diagnostic devices and reagents for veterinary and clinical use.

    VIRBAC

    Virbac is a French public company founded in 1968 with 6,442 employees. It specializes in veterinary pharmaceuticals and animal health products.

    Reasons to Buy this Report

    • Market-Specific Sizing Data : Access precise valuation figures for New Zealand's companion animal diagnostic market with 2026 baseline and 2031 forecasts, enabling accurate business planning and investment decisions.
    • Growth Trajectory Analysis : Understand the 7.6% CAGR specific to New Zealand and how it compares to global trends, identifying regional growth drivers and market maturity indicators.
    • Pet Owner Behavior Insights : Gain detailed understanding of New Zealand pet owners' diagnostic preferences, preventive healthcare spending patterns, and willingness to invest in advanced veterinary services.
    • Competitive Positioning Strategy : Develop targeted market entry or expansion strategies with New Zealand-specific competitive landscape analysis, regulatory environment, and veterinary clinic distribution data.
    • Regional Investment Opportunities : Identify high-potential segments within New Zealand's market, including urban vs. rural demand variations, emerging diagnostic technologies, and underserved geographic areas.

    Frequently asked questions

    What is the current size of New Zealand's companion animal diagnostic market?

    New Zealand's companion animal diagnostic market is valued at USD 15.0 million in 2026.

    What is the projected market size for New Zealand by 2031?

    New Zealand's companion animal diagnostic market is forecast to reach USD 21.6 million by 2031.

    What is the CAGR for New Zealand's companion animal diagnostic market?

    New Zealand's companion animal diagnostic market is expected to grow at a compound annual growth rate of 7.6% from 2026 to 2031.

    What factors are driving growth in New Zealand's companion animal diagnostic market?

    Growth in New Zealand is driven by increasing pet ownership, rising consumer awareness of pet health, advanced veterinary infrastructure, and strong animal welfare standards.

    Which diagnostic segments are growing fastest in New Zealand?

    Point-of-care testing, imaging diagnostics, and laboratory services are among the fastest-growing segments in New Zealand's companion animal diagnostic market.

    RESEARCH METHODOLOGY

    This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

    Secondary Research

    This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the companion animal diagnostics market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

    Primary Research

    In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the companion animal diagnostics market. Primary sources from the demand side include R&D product development teams in animal health companies, veterinary clinicians, diagnostic laboratory managers, and procurement heads at veterinary reference laboratories.

    Companion Animal Diagnostic Market Size, and Share

    Note: C-level executives include CEOs, COOs, CTOs, and VPs. Other designations include sales, marketing, and product managers.
    Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the companion animal diagnostics market was determined through data triangulation across three approaches, as described below. After each approach, the weighted average of the three was calculated based on the level of assumptions used in each.

    Companion Animal Diagnostic Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed as applicable to complete the overall market engineering process and obtain exact statistics for all segments and subsegments.

    Market Definition

    Companion animal diagnostics use plasma, serum, blood, urine, feces, and tissue samples to detect, monitor, and manage diseases and health conditions in dogs, cats, horses, and other household pets. The companion animal diagnostics market includes diagnostic instruments, test kits, reagents, and consumables used in veterinary clinics and laboratories, covering technologies such as clinical chemistry analyzers, hematology analyzers, immunodiagnostics and ELISA test kits, urinalysis systems, molecular diagnostic assays, glucose monitoring systems, and blood gas–electrolyte analyzers. These products support routine wellness screening, disease diagnosis, treatment monitoring, and preventive healthcare in companion animals.

    Key Stakeholders

    • Companion animal diagnostic manufacturers
    • Companion animal diagnostic distributors and suppliers
    • Companion animal R&D companies
    • Veterinary reference laboratories
    • Veterinary hospitals and clinics
    • Veterinary universities and research institutes
    • Government associations
    • Market research and consulting firms
    • Venture capitalists and investors
    • Distributors, channel partners, and third-party suppliers

    Report Objectives

    • To define, describe, segment, and forecast the companion animal diagnostics market by product, technology, application, animal type, end user, and region
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall companion animal diagnostics market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the companion animal diagnostics market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the companion animal diagnostics market and comprehensively analyze their core competencies and market shares
    • To analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

    Available customizations:

    Based on the given market data, MarketsandMarkets offers customization to meet your company’s specific needs. The following customization options are available for the report:

    Company Information
    • Detailed analysis and profiling of additional market players (up to 5)
    Geographic Analysis
    • Further breakdown of the Rest of European companion animal diagnostics market into Austria, Finland, Switzerland, and other countries
    • Further breakdown of the Rest of Latin American companion animal diagnostics market into Colombia, Chile, and other countries
    Competitive Landscape Assessment
    • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the companion animal diagnostics market
    • Competitive leadership mapping for established players in the US

     

    Get the Full Companion Animal Diagnostic Market Report

    Full forecast, segment splits, and company analysis for all Companion Animal Diagnostic Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status